Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer incidence in sites potentially related to occupational exposures: 58 years of follow-up of firefighters in the Norwegian Fire Departments Cohort. | Scand J Work Environ Health | 2022 | 35015085 | PubTator, text mining | PubMed |
| Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression. | Gut | 2022 | 35012996 | PubTator, text mining | PubMed |
| Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. | Stem Cell Res Ther | 2022 | 35012666 | PubTator, text mining | PubMed |
| Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses. | Molecules | 2022 | 35011529 | PubTator, text mining | PubMed |
| Clinicopathological and genetic study of a rare occurrence: Malignant transformation of fibrous dysplasia of the jaws. | Mol Genet Genomic Med | 2022 | 34989160 | PubTator, text mining | PubMed |
| Recapitulating human myogenesis ex vivo using human pluripotent stem cells. | Exp Cell Res | 2022 | 34973262 | PubTator, text mining | PubMed |
| Pathogenesis and virulence of Candida albicans. | Virulence | 2022 | 34964702 | PubTator, text mining | PubMed |
| Surface phenotypes of naive and memory B cells in mouse and human tissues. | Nat Immunol | 2022 | 34937918 | PubTator, text mining | PubMed |
| Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA). | Breast Cancer Res Treat | 2022 | 34935096 | PubTator, text mining | PubMed |
| Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. | Saudi J Biol Sci | 2022 | 34924802 | PubTator, text mining | PubMed |
| Characterization of the diffusion signal of breast tissues using multi-exponential models. | Magn Reson Med | 2022 | 34904726 | PubTator, text mining | PubMed |
| Design considerations for piezoelectrically powered electrical stimulation: The balance between power generation and fatigue resistance. | J Mech Behav Biomed Mater | 2022 | 34864397 | PubTator, text mining | PubMed |
| Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy. | Pharmacol Res | 2022 | 34863822 | PubTator, text mining | PubMed |
| Improved risk prediction of chemotherapy-induced neutropenia-model development and validation with real-world data. | Cancer Med | 2022 | 34859963 | PubTator, text mining | PubMed |
| miR-362-3p suppresses ovarian cancer by inhibiting LRP8. | Transl Oncol | 2022 | 34839107 | PubTator, text mining | PubMed |
| Possibility of exosome‑based coronavirus disease 2019 vaccine (Review). | Mol Med Rep | 2022 | 34821373 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Predictive Accuracy of the American College of Surgeons Risk Calculator in Patients Undergoing Major Lower Extremity Amputation. | Ann Vasc Surg | 2022 | 34788705 | PubTator, text mining | PubMed |
| An evaluation of a national mass media campaign to raise public awareness of possible lung cancer symptoms in England in 2016 and 2017. | Br J Cancer | 2022 | 34718357 | PubTator, text mining | PubMed |
| Novel Molecules derived from 3-O-(6-galloylglucoside) inhibit Main Protease of SARS-CoV 2 In Silico. | Chem Zvesti | 2022 | 34629698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=49